Schauer A, Barthel P, Adams V, Linke A, et al. Pharmacological Pre- and Postconditioning With Levosimendan Protect H9c2 Cardiomyoblasts From Anoxia/Reoxygenation-induced Cell Death via PI3K/Akt Signaling. J Cardiovasc Pharmacol 2021;77:378-385.
PMID: 33662980